[HTML][HTML] Nanotechnologies for the delivery of biologicals: Historical perspective and current landscape

M Durán-Lobato, AM López-Estévez… - Advanced Drug Delivery …, 2021 - Elsevier
Biological macromolecule-based therapeutics irrupted in the pharmaceutical scene
generating a great hope due to their outstanding specificity and potency. However, given …

Functional antibody delivery: Advances in cellular manipulation

KC Koch, GN Tew - Advanced Drug Delivery Reviews, 2023 - Elsevier
The current therapeutic antibody market in the US consists of 100 antibody-based products
and their market value is expected to explode beyond $300 billion by 2025. These therapies …

Improved delivery of Mcl-1 and survivin siRNA combination in breast cancer cells with additive siRNA complexes

T Santadkha, W Skolpap, R KC, A Ansari… - Investigational New …, 2022 - Springer
This study aimed at investigating the influence of commercial transfection reagents (Prime-
Fect, Leu-Fect A, and Leu-Fect C) complexed with different siRNAs (CDC20, HSP90, Mcl-1 …

Targeting Gαi2 in neutrophils protects from myocardial ischemia reperfusion injury

D Köhler, V Leiss, L Beichert, S Killinger… - Basic Research in …, 2024 - Springer
Neutrophils are not only involved in immune defense against infection but also contribute to
the exacerbation of tissue damage after ischemia and reperfusion. We have previously …

Post-genomic platform for development of oligonucleotide vaccines against RNA viruses: Diamond cuts diamond

VV Oberemok, OA Andreeva, KV Laikova… - Inflammation …, 2022 - Springer
The coronavirus pandemic has starkly demonstrated the need to create highly effective
vaccines against various viral diseases. The emerging new platforms for vaccine creation …

Development of pepper vein banding virus chimeric virus-like particles for potential diagnostic and therapeutic applications

P Sabharwal, C Sushmitha, CK Amritha, U Natraj… - Archives of …, 2020 - Springer
Monoclonal antibodies have attracted wide attention in therapeutics owing to their high
efficacy, low toxicity, and specific targeting. However, antibodies cannot cross the cell …

[PDF][PDF] Predictive modelling and simulation for taming the chance and luck in biologics drug discovery.

A Sepp - Proceedings of the Estonian Academy of Sciences, 2023 - kirj.ee
Three Pillars of Survival paradigm in the pharmaceutical drug discovery stipulates that a
drug candidate is more likely to reach Phase III if it meets the following criteria: 1) it reaches …

[ЦИТИРОВАНИЕ][C] Targeting Gα

D Köhler, V Leiss, L Beichert, S Killinger, D Grothe… - 2024